MISSION VIEJO, Calif., Nov. 10, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. ("MYnd") (OTCQB:MYAN), announces publication of "The Use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to Personalize Pharmacotherapy" by the Journal of Neuropsychiatric Disease and Treatment. The publication will be featured on "The Lead" with Jake Tapper, airing on CNN on Veteran's Day, November 11, 2016. In the randomized, controlled, double blind trial, doctors used either "treatment as usual" or MYnd Analytics' PEER Interactive to determine a course of treatment based on a patient's brain function. PEER Interactive uses algorithms and a database, consisting of outcomes from more than 10,000 individuals, to generate an objective report which can help a physician select an appropriate mental health medication for an individual as opposed to "treatment as usual" which involves a significant degree of trial and error. In this study service members whose doctors followed a machine learning treatment recommendation in their selection of medications experienced significant improvement in their mental health conditions: depression scores improved by 144%, post-traumatic stress disorder (PTSD) scores improved by 139%, and suicidal ideation was reduced by 75% when compared with patients whose doctors did not follow the PEER Interactive recommendations. Clinical Trial Demonstrates Improvement in Depression, Suicidality, and Post Traumatic Stress is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/eabba10f-c773-450a-90c5-2eabfbb33f73 "The best way we can honor veterans is to make sure that their treatments work," said George Carpenter, CEO of MYnd Analytics. "Every patient deserves access to objective, evidence-based, personalized treatments. We brought PEER to the military first because we believed it could help doctors save lives." The study was the fourth scientific replication of previous studies, all of which demonstrated the efficacy of PEER technology in improving patient outcomes. An additional replication study has started with Canadian Forces and a further study of veterans is forthcoming in the United States. PEER Interactive is a predictive medicine technology developed by MYnd Analytics, Inc. (OTCQB:MYAN), which combines an EEG scan of brain function with a registry of long-term outcomes for over 10,000 psychiatric patients.